Dermatologic Therapy

Papers
(The TQCC of Dermatologic Therapy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Case report: Pyogenic granuloma—just salt, a simple and pain‐free treatment67
Switch from ustekinumab to guselkumab in patients with psoriasis in real clinical practice using the “minimal disease activity” parameter62
Issue Information60
Exploring and expanding frontiers in dermatology: Indigenous African dermatology48
Cryptococcal meningitis associated with interleukin‐17 inhibitor use for psoriasis46
Epidemiology, clinical presentation, and management of pemphigoid nodularis: An update from Iran43
Fat herniation over striae distansea in focal dermal hypoplasia treated with 2940 nm Er: YAG Laser41
Combined treatment with omalizumab and secukinumab in a patient with chronic spontaneous urticaria and psoriasis39
Macrophage Migration Inhibitory Factor and Gene Polymorphism (rs755622G>C) in Unstable Vitiligo Patients38
Reply to “A case of symmetrical drug‐related intertriginous and flexural exanthema‐like eruption associated with Pfizer COVID ‐19 vaccination” by Manaa et al.38
Ultraviolet A Combined with Narrow‐Band Ultraviolet B is an Effective Treatment Modality for Early Folliculotropic Mycosis Fungoides and Early Mycosis Fungoides Refractory to Narrow‐Band Ultraviolet B38
Intrapleural infections in patients with subcutaneous panniculitis‐like T‐cell lymphoma are susceptible to hemophagocytic lymphohistiocytosis35
The case of granuloma annulare associated with SARS‐CoV ‐2 infection35
Two birds with one stone: Successful treatment with methotrexate in a patient with generalized eruptive keratoacanthoma of Grzybowski and rheumatoid arthritis35
The potential role for topical imiquimod in the treatment of chronic mucocutaneous candidiasis caused by gain‐of‐function mutation in STAT1 : A case‐report34
Cutaneous lupus erythematosus variants responsive to J anus kinase inhibition33
Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series33
Ulcerative injection site reaction after third COVID ‐19 vaccine dose with mRNA ‐127332
Dapsone in hidradenitis suppurativa: A case series of 56 patients32
Treatments for disease damage in cutaneous lupus erythematosus: A narrative review32
Psoriasiform dermatitis induced by dupilumab successfully treated with upadacitinib31
31
COVID ‐19 vaccine‐induced urticarial vasculitis31
Comparison of noninvasive screening tools for hepatic fibrosis, association with methotrexate cumulative dose, and risk factors in psoriasis patients30
Severe hidradenitis suppurativa (acne inversa) associated with focal segmental glomerulosclerosis and gout partially responsive to canakinumab30
Real‐World Guselkumab Response and Drug Survival in Australian Patients With Psoriasis: Results From the Australasian Psoriasis Registry29
Dupilumab dose spacing after initial successful treatment or adverse events in adult patients with atopic dermatitis: A retrospective analysis29
Tofacitinib in resistant chronic actinic dermatitis: A case series28
Comparison of Green‐Synthesized Silver Nanoparticle Shampoo Created by Moringa and Bergamot Extraction Versus 2% Ketoconazole Shampoo for Scalp Seborrheic Dermatitis: A Prospective, Randomized, Double28
New‐onset systemic lupus erythematosus after ChAdOX1 nCoV‐19 and alopecia areata after BNT162b2 vaccination against SARS‐CoV‐228
Topical Timolol for ingrown nail post‐avulsion refractory wound27
Microneedle fractional radiofrequency for atrophic acne scars: In vivo evaluation of results by 3D analysis and reflectance confocal microscopy27
Seroconversion after anti‐SARS‐CoV ‐2 mRNA vaccinations among moderate‐to‐severe psoriatic patients receiving systemic biologicals27
Children atopic dermatitis: Diagnosis, mimics, overlaps, and therapeutic implication27
Successful treatment of erythema nodosum leprosum with apremilast26
Dufourmentel flap for surgical treatment of medium‐sized congenital melanocytic nevi on the extremities26
Long‐term efficacy of telemedicine for patients with locally advanced basal cell carcinoma during COVID‐19 pandemic26
A daily regimen of a ceramide‐dominant moisturizing cream and cleanser restores the skin permeability barrier in adults with moderate eczema: A randomized trial26
Letter in response to “Reply to: Topical cyclosporine 5% cream in Zoon's balanitis resistant to other therapies: A case report”26
Efficacy of sonidegib for basal cell carcinoma in a patient affected by multiple infectious diseases25
Efficacy and safety of intralesional tuberculin purified protein derivative versus cryotherapy in the treatment of warts: An assessor‐blinded, randomized controlled trial25
25
24
24
Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily24
The efficacy of polycaprolactone filler injection on enlarged facial pores24
Cutaneous adverse reactions to coronavirus vaccines: A Saudi nationwide study24
Mesenchymal Stem Cells‐Derived Extracellular Vesicles as Nanotherapeutics: An Application for Skin Wound Healing23
Multiple eruptive squamoproliferative lesions during anti‐PD1 immunotherapy for metastatic melanoma: Pathogenesis, immunohistochemical analysis and treatment23
Therapeutic options for perifolliculitis capitis abscedens et suffodens: A review23
Erbium‐YAG Laser Treatment for Recalcitrant Warts: A Retrospective Analysis23
Clinical evidence on the use of brodalumab for the treatment of psoriasis in Greece: Experience from clinical practice of four tertiary hospitals23
A case of sintilimab‐induced SJS / TEN :Dermatologic adverse reactions associated with programmed cell death protein‐1 inhibitors23
Comparison of efficacy, safety and satisfaction of latanoprost versus minoxidil, betamethasone and in combination in patients with alopecia areata: A blinded multiple group randomized controlled trial22
Successful treatment of secukinumab‐resistant palmoplantar pustulosis by Dupilumab: A case report21
Topical treatments for erythromelalgia21
Vaccine‐induced dermatomyositis following COVID ‐19 vaccination21
Dupilumab‐induced psoriasis in a patient with atopic dermatitis and alopecia totalis: A case report and literature review20
Platelet rich plasma in treatment of topical steroid damaged face: A retrospective analytical study20
Real‐world experience of secukinumab in moderate to severe psoriasis patients in Thailand: Characteristics, effectiveness, and safety20
Ocular involvement and complications of lichen planus, lichen planus pigmentosus, and lichen planopilaris: A comprehensive review19
Sleep loss and the skin: Possible effects of this stressful state on cutaneous regeneration during nocturnal dermatological treatment and related pathways19
Emerging paradigm shift toward proactive topical treatment of psoriasis: A narrative review19
A Retrospective Study to Investigate Safety of Receiving Interleukin‐17 Monoclonal Antibody for Psoriasis Patients With Hepatitis B Virus19
Dupilumab: Advances in the off‐label usage ofIL4/IL13antagonist in dermatoses19
Isotretinoin as chemoprophylaxis for cutaneous malignancies in Muir‐Torre syndrome: A novel concept19
Dupilumab‐induced Urticaria19
Drug Survival in the Treatment of Mucosal Lichen Planus: A Retrospective Multicenter Study19
Safe use of tocilizumab in rheumatic patients with Kaposi's sarcoma19
Terbinafine induced pancreatitis in a healthy young adult male18
Applicability of glucocorticoid toxicity index in pemphigus: Comparison between two groups of rituximab‐treated and rituximab‐naïve patients18
Ultrasound‐guided injection of intralesional steroids in acute hidradenitis suppurativa lesions: A prospective study18
Immunotherapy in transplanted patients: A special population that can no longer be ignored18
Monitoring oral propranolol for infantile hemangiomata18
Generalized pustular psoriasis recurring during pregnancy and lactation successfully treated with ixekizumab18
Chilblain or perniosis‐like skin lesions in children during the COVID ‐19 pandemic: A systematic review of articles18
COVID ‐19 severity and SARS‐Cov ‐2 vaccine safety in pemphigus patients18
Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy17
Issue Information17
Photodynamic therapy for pediatric genital warts: A case report17
Real‐world efficacy of proactive maintenance treatment with delgocitinib ointment twice weekly in adult patients with atopic dermatitis17
Investigating the efficacy and safety of calcipotriol/betamethasone dipropionate foam and laser microporation for psoriatic nail disease—A hybrid trial using a smartphone application, optical coherenc17
Cover Image, Volume 34, Issue 516
Paradoxical Pandora's box of pigmentary side effects by imatinib mesylate in case of chronic myeloid leukemia16
Dramatic resolution of cutaneous lymphoid hyperplasia after receiving intravenous immunoglobulin for COVID ‐1916
A case of blastic plasmacytoid dendritic cell neoplasm limited to skin16
Successful treatment of atopic dermatitis refractory to dupilumab with baricitinib16
A Novel Regimen of Transdermal Botulinum Toxin Delivery Using Fractional Microneedling Radiofrequency for Treatment of Erythema in Rosacea15
Cannabinoids interaction with transient receptor potential family and implications in the treatment of rosacea15
Figurate purpuric eruption post‐COVID‐19 vaccination15
Unusual occurrence of nail lichen planus in a child and response to treatment15
15
Evaluation of short‐term (16‐week) effectiveness and safety of guselkumab in patients with psoriasis: A prospective real‐life study on the Chinese population15
Therapeutic management and clinical remission for patients with psoriasis and psoriatic arthritis in a specialized dermatological‐rheumatological center15
Erythema multiforme‐like drug eruption associated with dupilumab treatment: Report of an unusual case15
The first case report of Pityriasis lichenoides chronica following COVID ‐19 mRNA vaccination15
Combination of low dose corticosteroids and antioxidants in treatment of cutaneous lichen planus15
Management of scarring HS fistulas with intralesional steroids14
Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial14
Biophysical and ultrasonographic changes of acute Old World cutaneous leishmaniasis skin lesions in comparison with uninvolved skin: A possible tool for non‐invasive14
A Phase IIIb, Multicentre, Interventional, Randomised, Placebo‐Controlled Clinical Trial Investigating the Efficacy and Safety of Guselkumab for the Treatment of Nonpustular Palmoplantar Psoriasis (G‐14
Dupilumab Therapy of Prurigo Nodularis: A Single‐Center, Real‐Life Observational Study14
Anti‐IL17 and anti‐IL23 biologic drugs for scalp psoriasis: A single‐center retrospective comparative study14
Serum Neurofilament Light Chain Levels Correlate With Skin Inflammation and Scratch Lesions in Patients With Pruritus14
Lichen planus pigmentosus inversus with nail involvement following COVID ‐19 vaccination: A case report14
Dissecting cellulitis of the scalp: A review on clinical characteristics and management options in a series of 14 patients14
Risk of cutaneous carcinogenesis with phototherapy in Indian subpopulation: A 10‐year analysis and a review of literature13
A case of chronic spontaneous urticaria unresponsive to ligelizumab successfully treated with omalizumab13
No antibody response in cutaneous manifestations associated with COVID‐19: An observational study of 64 cases with microbiological and clinical characterization13
Topical immunotherapy treatment of alopecia areata with diphenylcyclopropenone: Regulatory T cells as biomarkers for treatment response13
Successful treatment with secukinumab in an HIV ‐positive psoriatic patient after failure of apremilast13
Evaluation of Efficacy and Safety of Topical Nanoliposomal Amphotericin B 0.4% Gel as a Potential Treatment for Onychomycosis: An Interventional Pilot Clinical Study13
Paradoxical psoriasis induced by anti‐ TNF ‐alpha successfully treated with brodalumab13
Bullous pemphigoid after inactivated COVID ‐19 vaccination: Case report13
New repair strategy: Treatment of V‐shaped divided nevus on eyelids with fish‐mouth flap13
The initial experience of COVID ‐19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy13
Improvement of dupilumab‐associated conjunctivitis after switching to upadacitinib in a patient with atopic dermatitis13
Chemical peeling with 35% glycolic acid for the treatment of disseminated facial verruca plana: A randomized, split‐face, evaluator‐blinded trial13
Pityriasis rosea infection in a COVID ‐19 patient successfully treated with systemic steroid and antihistamine via telemedicine: Literature update of a possible prod13
Intralesional interleukin‐2 augmentation therapy in treatment‐refractory melanoma13
Treatment of melasma with platelet‐rich plasma: A self‐controlled clinical trial13
Fractional CO 2 laser to improve noticeable scars after skin cancer surgery: An appraisal by the patients, laype13
Response to comment on “Merkel cell carcinoma: An updated review of pathogenesis, diagnosis, and treatment options”13
Psoriasis with Sputnik V vaccine, a potential triggering factor13
Metabolic syndrome in patients with Alopecia Areata: A case‐control study13
The effect of baricitinib add‐on therapy in atopic dermatitis patients treated with dupilumab12
Cutaneous adverse events related to COVID ‐19 vaccines: A cross‐sectional questionnaire‐based study of 867 patients12
Treatment of chronic venous disorder: A comprehensive review12
Is cysteamine use effective in the treatment of melasma? A systematic review and meta‐analysis12
A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double‐blind, placebo‐controlled trial12
Development of pemphigus vulgaris during treatment with dipeptidyl peptidase‐4 inhibitors: a case report12
Losartan as therapy for recessive dystrophic epidermolysis bullosa: Report of three cases12
Benefits of topical hyaluronic acid for skin quality and signs of skin aging: From literature review to clinical evidence12
Patient with atopic dermatitis, hyper IgE syndrome and ulcerative colitis, treated successfully with dupilumab during pregnancy12
Efficacy and safety of apremilast monotherapy in moderate‐to‐severe plaque psoriasis: A systematic review and meta‐analysis12
Locally advanced basal cell carcinoma: Real‐life data with sonidegib12
Contact skin radiotherapy (brachytherapy) for the treatment of non‐melanoma skin cancers during COVID ‐19 pandemic12
New‐onset bullous pemphigoid after inactivated Covid‐19 vaccine: Synergistic effect of the Covid‐19 vaccine and vildagliptin11
New onset of pemphigus foliaceus following BNT162b2 vaccine11
Apremilast for the treatment of palmo‐plantar non‐pustular psoriasis: A real‐life single‐center retrospective study11
Randomized controlled trial to compare the effectiveness and safety of low dose dexamethasone oral mini‐pulse versus diphenylcyclopropenone contact sensitisation in severe pediatric alopecia areata11
Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate11
Matching the dose to the disease: Successful treatment of recalcitrant pyoderma gangrenosum using high‐dose secukinumab11
Topical ivermectin‐induced transient flare of rosacea as a host reaction to killed Demodex mites preventable by short‐term use of topical corticosteroid11
Assessing the Efficacy and Safety of Intradermal Injection of Different Doses of Botulinum Toxin Type A: A Randomized, Double‐Blind, Placebo‐Controlled, Split‐Face Pilot Study in Rosacea Patients with11
Cutaneous squamous cell carcinoma of head and neck region: A single center analysis of 1296 tumors with clinical characteristics, comorbidities, treatment, and sun‐protection 11
Alcohol flushing during dupilumab therapy: An emerging adverse event11
Characteristics of granuloma annulare in reflectance confocal microscopy11
Dupilumab therapy following JAK inhibitor withdrawal in moderate–severe atopic dermatitis11
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID‐1911
SARS‐CoV‐2 vaccination‐induced cutaneous vasculitis: Report of two new cases and literature review11
Combination of debridation, vacuum system, and epidermal micrografting system for the treatment of an Exserohilum rostratum skin infection in a pediatric cancer patient11
Inflammatory Bowel Disease and Rosacea: A Two‐Sample Mendelian Randomization Study11
11
Four cases of hemorrhagic herpes zoster associated with dabigatran therapy11
An uncommon phenomenon with common medications in a case of bi‐segmental vitiligo11
Can we increase the success of scabies treatment? The effect of removing tunnels from patients in the success of scabies treatment11
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study11
Microneedling and5‐flurouracilcan enhance the efficacy ofnon‐culturedepidermal cell suspension transplantation for resistant acral vitiligo11
“Covid arm”: Abnormal side effect after Moderna COVID ‐19 vaccine10
Hydroxychloroquine‐induced acute generalized exanthematous pustulosis in an orofacial granulomatosis patient with homozygous IL36RN 10
A real‐life experience as a proof of Guselkumab effectiveness and safety in patients with moderate to severe psoriasis10
The Safety and Efficacy of Macrofocused Ultrasound without Visualization on Enlarged Facial Pores among Thai Patients: A Pilot Study10
The empty stromal sandwich sign: A potential for false negatives in Mohs micrographic surgery slides when evaluating basal cell carcinoma10
Risankizumab shows high efficacy and maintenance in improvement of response until week 5210
A practical guide to the safety of topical medications for the pediatric population10
Tofacitinib for the treatment of erythematotelangiectatic and papulopustular rosacea: A retrospective case series10
Spironolactone in dermatology10
Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population10
Delayed urticaria after the third dose of mRNA COVID19 vaccine: A case series10
Facial rejuvenation by microneedling with irradiated amniotic collagen matrix compared to platelet rich plasma10
Tofacitinib as a pragmatic treatment choice for alopecia areata: A retrospective review10
Longdan X iegan formula as adjuvant therapy for acute herpes zoster: A meta‐analysis of randomized controlled trials10
Five hundred and thirty‐two‐nanometer Q ‐switched Nd:Yag laser with larger fractional spot: A novel and safe technique to treat C 10
Low rate of scalp biopsy in systemic lupus erythematosus patients and the potential for misdiagnosis10
Treatment of lymphomatoid papulosis resistant to methotrexate therapy with intralesional interferon‐alpha‐2a10
Fully home‐based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study10
Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant)10
10
Evaluation of combination use of phenytoin cream 1% and fractionalCO2laser in treatment of stablenonsegmentalvitiligo: A pilot study10
The efficacy and safety of topical Tretinoin combined with superficial X ‐ray therapy ( SXRT ) 10
Treatment for Aging Skin with Multifrequency Radiofrequency10
Silicone gel sheets in treatment of pseudo‐knuckle pads: a case report10
“Azole menace”‐An underappreciated trigger perpetuating the epidemic of antifungal therapeutic failure in cutaneous mycoses10
The Efficacy and Safety of a Low‐Fluence 1064 nm Picosecond ND‐YAG Laser Compared with Those of a Low‐Fluence Photoacoustic Therapy Pulsed (PTP) Mode 1064 nm Q‐Switched ND‐YAG Laser for Treatment of M10
Real life long‐term efficacy and safety of ixekizumab in moderate‐to‐severe psoriasis: A 192 weeks multicentric retrospective study— IL PSO ( Italia10
A case of herpes zoster ophthalmicus after third dose of Comirnaty ( BNT162b2 mRNA ) vaccine9
More data on erythema annulare centrifugum induced by COVID ‐19 vaccination9
Home treatment of single cutaneous warts combining face‐to‐face and teledermatology consultation: A new perspective9
Impact on health‐related quality of life and symptoms of anxiety and depression after 32 weeks of Dupilumab treatment for moderate‐to‐severe atopic dermatitis9
Dermatoscopic assessment of treatment response in patients undergoing autologous non‐cultured epidermal cell suspension for the treatment of stable vitiligo: A prospective study9
Guselkumab does not appear to influence the IgG antibody response to SARS‐CoV ‐29
Comparative study of treatment methods for benign lichenoid keratosis of the face9
Split body comparative clinical and radiological study of fractional CO 2 laser versus carboxytherapy in treatme9
Cutaneous T cell lymphoma treated with mogamulizumab monotherapy and mogamulizumab plus etoposide combined therapy: A real‐world case series9
Real world experience of brodalumab treatment in patients with moderate‐to‐severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study9
Study of Treatment and Patient Factors of Hemoporfin‐Photodynamic Therapy for Port‐Wine Stains9
A Gianotti‐Crosti ‐like eruption in the setting of SARS‐CoV ‐2 infection9
The effect of latanoprost 0.005% solution in the management of scalp alopecia areata, a randomized double‐blind placebo‐controlled trial9
9
Efficacy of switches within the class of IL ‐17 inhibitors: An analysis of data from the Czech nationwide registry of psoriatic patients receiving biological/targete9
Clinical, dermoscopic, and histopathologic evaluation of vitamin C versus PRP , with microneedling in the treatment of mixed melasma: A split‐face, comparative study9
Secukinumab for PASS syndrome: A new choice for therapeutic challenge?9
Basal cell carcinoma of the eyelid margin: Dermoscopic clues in a case series9
The efficacy and safety of dupilumab for the treatment of atopic dermatitis among Chinese patients in clinical practice: A single‐center retrospective study9
The Synergetic Roles of Stromal Vascular Fraction (SVF) and Extracellular Matrix (ECM) on Fat Graft Retention in Nude Mice9
Efficacy and Safety of Tofacitinib in Patients With Refractory Prurigo Nodularis: A 16‐Week, Single‐Center, Prospective, Observational Pilot Study9
Late‐Onset Maculopapular Eruptions Associated with Elevated Varicella‐Zoster Virus Complement‐Fixing Antibody Titers following BNT162b2 mRNA COVID‐19 Vaccination in Older Adult Japanese Patients: A Cr9
Hyaluronic Acid Dissolving Microneedles and Nonablative Fractional Laser for Infraorbital Wrinkles: A Prospective, Randomized, Split‐Face Study9
Evaluating the risk‐to‐benefit ratio of using cotrimoxazole as a pneumocystis pneumonia preventative intervention among pemphigus patients treated with rituximab: A retrospective study with 494 patien9
Successful therapy of disseminated patch‐type granuloma annulare with upadacitinib in a patient with rheumatoid arthritis9
Dupilumab combined with low‐dose systemic steroid therapy improves efficacy and safety for bullous pemphigoid9
Early time to recurrence predicts worse survival in patients with localized or regionally advanced cutaneous melanoma8
The Efficacy and Safety of Combining Phototherapy and Topicals in the Treatment of Atopic Eczema: A Systematic Review of the Current Evidence8
The oral cavity and gastric involvement in mycosis fungoides while on systemic bexarotene therapy: A rare case report8
Immunocryosurgery is a safe and feasible treatment for basal cell carcinoma and Bowen disease in renal transplant recipients8
Surgery combined with photodynamic therapy versus surgery alone for the treatment of non‐melanoma skin cancer and actinic keratosis: A retrospective cohort study8
COVID vaccination in patients under treatment with rituximab: A presentation of two cases from Iran and a review of the current knowledge with a specific focus on pemphigus8
Does Lifestyle Affect Isotretinoin Tolerance in Patients with Acne? A Retrospective Cohort Study8
A Retrospective Statistical Analysis of Vitiligo Exacerbation after COVID‐19 Vaccination in China8
Microneedling with topical vitamin C versus microneedling with topical insulin in the treatment of atrophic post‐acne scars: A split‐face study8
Efficacy and safety of chitosan‐based bio‐compatible dressing versus nanosilver (Acticoat TM ) dressing in treatment of recalcitrant diabetic wounds: A randomized cl8
Successful treatment of eruptive pyogenic granuloma with propranolol8
A case of new‐onset acute generalized pustular psoriasis following Pfizer‐BioNTech COVID ‐19 vaccine8
Topical finasteride: A potential therapeutic option for hidradenitis suppurativa8
Keloid of earlobe treated with a combination of pneumatic injector device and CO 2 fractional laser8
Issue Information8
A Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial to Assess the Efficacy of a Nutritional Supplement in Female Androgenic Alopecia8
Acne care in health care providers during the COVID ‐19 pandemic: A national survey8
A3669G Polymorphism of Glucocorticoid Receptor Is More Present in Patients With Pemphigus Vulgaris Than in Healthy Controls and Contributes to Steroid‐Resistance8
Evaluating the tolerance and efficacy of laser‐assisted delivery of tranexamic acid, niacinamide, and kojic acid for melasma: A single center, prospective, split‐face trial8
High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts8
Sonidegib treatment in patients with locally advanced basal cell carcinoma8
Platelet‐rich plasma versus carboxytherapy for the treatment of periocular hyperpigmentation; which approach is superior?8
Thoughts on surgical excision of onychopapilloma8
Therapeutic efficacy and safety of three different modalities in pediatric patients with plantar warts8
More than a genital psoriasis8
Exosomes as novel player in dermatologic field8
Deep Learning Algorithms for Assessment of Post‐Thyroidectomy Scar Subtype8
Early rituximab treatment is associated with increased and sustained remission in pemphigus patients: A retrospective cohort of 99 patients8
Mask‐Acne Prevalence and Risk Factors during the COVID‐19 Pandemic: A Cross‐Sectional Single Institution Study8
Latest combination therapies in psoriasis: Narrative review of the literature8
Successful treatment of tinea capitis caused by Microsporum canis in a 23‐day‐old newborn with itraconazole pulse therapy and a review of the literature8
Treatment of Frontal Fibrosing Alopecia7
Topical opioid use in dermatologic disease: A systematic review7
Comparison of clinical results of oral tranexamic acid and platelet rich plasma therapies in melasma treatment7
Ferulic acid – A novel topical agent in reducing signs of photoaging7
Utility of phototherapy in patients with systemic sclerosis: Systematic review7
Tildrakizumab: A new therapeutic option for erythrodermic psoriasis?7
A real life experience with ustekinumab: The effectiveness of 45 mg on patients greater than 80 kg but lower than 100 kg7
0.1394350528717